Holen Sie sich die Stockscreener-App
2.78
5.44%
-0.16
Vorhandelsmarkt:
2.69
-0.09
-3.24%
Imunon Inc Aktie (IMNN) Neueste Nachrichten
Imunon Inc. Expands Market Footprint Amid Strategic Deals and Financial Challenges - timothysykes.com
IMUNON's IMNN-001 Shows Continued Gains In Overall Survival In Phase 2 Ovarian Cancer Trial - RTTNews
Imunon (IMNN) Reports Promising Phase 2 OVATION 2 Trial Results - GuruFocus
IMUNON reports improved survival data for ovarian cancer therapy By Investing.com - Investing.com UK
IMUNON Reports Updated Phase 2 Data Showing Continued - GlobeNewswire
Guidance Update: Can Imunon Inc reach all time highs this yearJobs Report & Safe Capital Investment Plans - baoquankhu1.vn
Aug Closing: Is Imunon Inc stock a good pick for beginners2026 Big Picture & Real-Time Volume Analysis Alerts - baoquankhu1.vn
IMUNON to Hold 2025 Financial Results and Business Update Conference Call on Tuesday, March 31, 2026 - marketscreener.com
IMUNON to outline 2025 results and IMNN-001 update March 31 - Stock Titan
IMUNON, Inc. Files Form 8-K with NASDAQ Listing and Company Details for March 2026 - Minichart
Imunon Expands At-The-Market Equity Offering Capacity - TipRanks
Imunon registers additional $7 million in shares under at-the-market offering - Investing.com
Imunon registers additional $7M, raising ATM capacity to $17M - TradingView
Imunon (NASDAQ: IMNN) boosts at-the-market stock program to $17M - Stock Titan
Imunon (NASDAQ: IMNN) ups ATM program by $7M to $17M capacity - Stock Titan
S P Trends: What is the next catalyst for Imunon Inc2026 Weekly Recap & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Dividend Watch: Will Imunon Inc outperform tech stocksQuarterly Profit Report & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Imunon Q2 2025 Earnings Preview - MSN
Imunon declares $0.15 dividend - MSN
Signal Recap: Will Imunon Inc outperform tech stocksGold Moves & Low Risk Entry Point Guides - baoquankhu1.vn
Market Overview: Is Imunon Inc a defensive stock2025 Key Highlights & Smart Swing Trading Techniques - baoquankhu1.vn
IMNN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
IMNN SEC FilingsImunon Inc 10-K, 10-Q, 8-K Forms - Stock Titan
IMNN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Imunon Inc expected to post a loss of $1.17 a shareEarnings Preview - TradingView
What risks investors should watch in Imunon Inc. stockWeekly Profit Report & Risk Controlled Swing Alerts - mfd.ru
Can Imunon Inc continue delivering strong returnsJuly 2025 Chart Watch & Reliable Breakout Forecasts - baoquankhu1.vn
Armistice Capital takes 9.99% stake in Imunon (IMNN) - Stock Titan
Will Imunon Inc. outperform small cap indexesWeekly Risk Report & Free Community Supported Trade Ideas - mfd.ru
Will Imunon Inc. outperform tech stocksQuarterly Trade Report & Technical Entry and Exit Alerts - mfd.ru
Should I invest in Imunon Inc. before earningsIPO Watch & Consistent Profit Trade Alerts - mfd.ru
FY2025 Earnings Estimate for Imunon Issued By HC Wainwright - Defense World
Imunon stock price target raised to $25 from $14 at H.C. Wainwright By Investing.com - Investing.com South Africa
Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Oncolytics Biotech (ONCY) and Imunon (IMNN) - The Globe and Mail
IMNN: Streamlining Operations to Focus on OVATION 3 - Smartkarma
Rate Hike: Will Imunon Inc outperform its industry peersJuly 2025 Drop Watch & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Imunon stock price target raised to $25 from $14 at H.C. Wainwright - Investing.com Australia
Imunon, Inc. Announces Retirement of Executive Vice President and Chief Scientific Officer Khursheed Anwer, Effective February 20, 2026 - marketscreener.com
Imunon sharpens focus on its promising pivotal Phase 3 ovarian cancer study - marketscreener.com
IMUNON rises on plan to shift resources to ovarian cancer therapy - TradingView
Imunon stock rises following strategic restructuring to focus on Phase 3 trial - Investing.com Nigeria
Imunon stock rises following strategic restructuring to focus on Phase 3 trial By Investing.com - Investing.com South Africa
Imunon announces orderly retirement of chief scientific officer - TipRanks
IMUNON, Inc. Announces Strategic Restructuring and Retirement of Chief Scientific Officer to Advance Phase 3 Clinical Trial - Quiver Quantitative
IMUNON SHARPENS FOCUS ON ITS PROMISING PIVOTAL PHASE 3 OVARIAN CANCER STUDY - One News Page
Resistance Check: Is MLTX stock a buy or sellGold Moves & Safe Entry Momentum Tips - baoquankhu1.vn
Stock Analysis: Can Imunon Inc sustain earnings growthTrade Ideas & Pattern Based Trade Signal System - baoquankhu1.vn
Imunon CEO says ‘poised for key milestones’ as company enters 2026 - MSN
Pullback Watch: Can Imunon Inc continue delivering strong returnsQuarterly Earnings Report & Weekly Market Pulse Alerts - baoquankhu1.vn
Aug Mood: What is Franklin BSP Realty Trust Incs debt to equity ratioPortfolio Gains Summary & Fast Gain Swing Alerts - baoquankhu1.vn
Is Imunon Inc. stock a good pick for beginnersQuarterly Earnings Summary & Verified Momentum Watchlists - bollywoodhelpline.com
IPO Launch: Why Imunon Inc stock is recommended by analystsJuly 2025 Volume & AI Driven Stock Price Forecasts - Bộ Nội Vụ
Aug Weekly: What is Five Below Incs revenue forecastPortfolio Performance Summary & Low Risk High Reward Ideas - baoquankhu1.vn
Head to Head Review: Allogene Therapeutics (NASDAQ:ALLO) and Imunon (NASDAQ:IMNN) - Defense World
Market Review: Will Imunon Inc stock deliver shareholder valueWeekly Earnings Recap & Consistent Profit Focused Trading Strategies - Bộ Nội Vụ
Imunon, Inc. (NASDAQ:IMNN) Receives $232.50 Average Price Target from Analysts - Defense World
Can Imunon Inc. stock maintain growth trajectoryMarket Movement Recap & Daily Entry Point Trade Alerts - Улправда
How Imunon Inc. stock performs in stagflationChart Signals & Expert Approved Momentum Trade Ideas - Улправда
Will Imunon Inc. stock deliver shareholder valueMarket Rally & Risk Controlled Stock Pick Alerts - Улправда
Can Imunon Inc. stock attract ESG capital inflowsQuarterly Trade Summary & High Conviction Buy Zone Picks - Улправда
Imunon Announces CFO Transition and Reappointment of Jeffrey Church - The Globe and Mail
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):